[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"case:lead-pharma-holding-bv-74987283:header:guest:personal:":3,"case:lead-pharma-holding-bv-74987283:overview:guest:personal::{}":78},{"id":4,"slug":5,"name":6,"trade_names":7,"status":8,"procedure":9,"procedure_type":10,"insolvency_number":29,"case_number":29,"declared_on":30,"terminated_on":14,"termination_reason":14,"kvk_number":31,"legal_form":32,"sbi":14,"court":35,"judge":38,"judge_source":39,"curator":41,"location":45,"counts":54,"pages":59,"follower_count":58,"report_count":55,"last_report_on":71,"last_update_at":72,"freshness":73,"linked":77},"01M4A8YZNJN0TM8MG4RBQG1D1P","lead-pharma-holding-bv-74987283","Lead Pharma Holding B.V.",[],"active","bankruptcy",{"id":11,"key":9,"family":12,"name":13,"short_name":14,"legal_basis":15,"features":19},"01M3Y8CPCPT53NPXHK39BWK1QY","insolvency","Faillissement",null,{"name":16,"provision":17,"url":18},"Faillissementswet","Titel I (art. 1 e.v.)","https:\u002F\u002Fwetten.overheid.nl\u002FBWBR0001860",[20,21,22,23,24,25,26,27,28],"reports","financials","creditors","assets","investigations","curator_workspace","appointments","court_decisions","portfolio_monitoring","F.01\u002F25\u002F320","2025-11-25","74987283",{"value":33,"source":34},"BV","kvk_open",{"name":36,"slug":37,"location":14},"Rechtbank Oost-Brabant","oost-brabant","mr. S.C.E.F. Moulen Janssen",{"type":40,"report_number":14,"published_on":14},"cir",{"name":42,"slug":43,"law_firm":14,"city":14,"verified":44},"mr. D.P. Schalken","dp-schalken",false,{"street":46,"house_number":47,"addition":14,"postal_code":48,"city":49,"municipality":49,"province":50,"lat":51,"lng":52,"kind":53,"source":40},"Kloosterstraat","9","5349AB","Oss","Noord-Brabant",51.760717,5.533719,"business",{"reports":55,"documents":56,"assets":57,"investigations":57,"news":58},8,10,6,0,{"overview":60,"reports":62,"financials":63,"investigations":64,"assets":65,"timeline":66,"documents":67,"news":68,"company":69,"compare":70},{"index":61,"ads":61},true,{"index":61,"ads":61},{"index":61,"ads":61},{"index":61,"ads":44},{"index":61,"ads":44},{"index":61,"ads":44},{"index":61,"ads":44},{"index":44,"ads":44},{"index":61,"ads":44},{"index":44,"ads":44},"2026-10-06","2026-10-08T19:39:43+00:00",{"last_checked_at":74,"last_reconciled_at":75,"stale":44,"status":76},"2026-10-08T18:00:16+00:00","2026-10-08T15:07:10+00:00","current",{"continued_from":14,"continued_as":14},{"data":79},{"summary":80,"changes":152,"kpis":221,"topics":265,"topics_report_number":158,"topics_report_date":159,"processing":333,"timeline":351,"documents":401,"sources":410,"curator_update":14,"news":412,"auctions":413},{"kind":81,"category":81,"sentences":82,"facts":130,"published_at":151},"template",[83,88,92,97,105,111,117,123],{"key":84,"params":85,"facts":86},"declared",{"procedure":9,"date":30,"court":36,"number":29},[87],"procedure",{"key":89,"params":90,"facts":91},"curator",{"name":42},[89],{"key":20,"params":93,"facts":96},{"count":94,"number":95,"date":71},2,4,[20],{"key":98,"params":99,"facts":103},"value",{"field":100,"value":101,"state":102,"qualifier":14,"number":95,"date":71},"estate_assets",55640.8,"known",[104],"value_estate_assets",{"key":98,"params":106,"facts":109},{"field":107,"value":108,"state":102,"qualifier":14,"number":95,"date":71},"concurrent_claims",30410.44,[110],"value_concurrent_claims",{"key":98,"params":112,"facts":115},{"field":113,"value":114,"state":102,"qualifier":14,"number":95,"date":71},"creditor_count",5,[116],"value_creditor_count",{"key":98,"params":118,"facts":121},{"field":119,"value":120,"state":102,"qualifier":14,"number":95,"date":71},"preferential_claims",171586.56,[122],"value_preferential_claims",{"key":124,"params":125,"facts":128},"topic",{"topic":126,"state":127,"number":95,"date":71},"causes_investigation","completed",[129],"topic_causes_investigation",{"company":131,"procedure":133,"curator":134,"reports":135,"value_estate_assets":136,"value_concurrent_claims":140,"value_creditor_count":143,"value_preferential_claims":146,"topic_causes_investigation":149},{"category":132},"official",{"category":132},{"category":132},{"category":132},{"category":137,"value_id":138,"reference_id":139},"automated",54650,399270,{"category":137,"value_id":141,"reference_id":142},54655,399275,{"category":137,"value_id":144,"reference_id":145},54654,399274,{"category":137,"value_id":147,"reference_id":148},54656,399276,{"category":137,"topic_id":150},91169,"2026-10-08T08:55:07+00:00",{"from":153,"to":156,"count":95,"groups":160},{"id":154,"number":94,"published_on":155},"01M4E0VQPEVVZ807SS8B8JEK6E","2026-04-07",{"id":157,"number":158,"published_on":159},"01M4E0VVEZCHRRBGXVRKC002PN",3,"2026-07-06",{"new":161,"changed":179,"completed":205,"ongoing":206,"no_longer_mentioned":220},[162],{"kind":124,"topic":163,"change":164,"from":14,"to":127,"source":165},"going_concern","new",{"id":166,"category":137,"method":167,"source_type":168,"document":169,"page":174,"section":175,"excerpt":176,"certainty":177,"curator_verified_at":14,"processed_at":178},488382,"deterministic","cir_report",{"id":170,"title":171,"report_number":158,"report_date":159,"published_on":159,"page_count":172,"url":173,"available":61},"01M4E0VWN3ZXAZDKAF414W3166","Verslag:  06-07-2026",13,"https:\u002F\u002Ffaillissement.app\u002Fdocuments\u002F01M4E0VWN3ZXAZDKAF414W3166.pdf",9,"6.8 Werkzaamheden doorstarten onderneming","De verkoop is afgerond en de koopsom is betaald. De rechten moeten nog w el geleverd w orden. Omdat de koper nog doende is met het opzetten van 3 de definitieve structuur, is daar tot heden mee gew acht, op verzoek van koper.",0.7,"2026-10-08T18:51:20+00:00",[180,191,198],{"kind":124,"topic":181,"change":182,"from":183,"to":184,"source":185},"bookkeeping_duty","changed","investigating","mentioned",{"id":186,"category":137,"method":167,"source_type":168,"document":187,"page":174,"section":188,"excerpt":189,"certainty":190,"curator_verified_at":14,"processed_at":178},488383,{"id":170,"title":171,"report_number":158,"report_date":159,"published_on":159,"page_count":172,"url":173,"available":61},"7.1 Boekhoudplicht","Voldaan.",0.5,{"kind":124,"topic":192,"change":182,"from":183,"to":184,"source":193},"director_liability",{"id":194,"category":137,"method":167,"source_type":168,"document":195,"page":56,"section":196,"excerpt":197,"certainty":190,"curator_verified_at":14,"processed_at":178},488385,{"id":170,"title":171,"report_number":158,"report_date":159,"published_on":159,"page_count":172,"url":173,"available":61},"7.5 Onbehoorlijk bestuur","Toelichting Er is geen sprake van onbehoorlijk bestuur.",{"kind":124,"topic":199,"change":182,"from":183,"to":184,"source":200},"paulianas",{"id":201,"category":137,"method":167,"source_type":168,"document":202,"page":56,"section":203,"excerpt":204,"certainty":190,"curator_verified_at":14,"processed_at":178},488386,{"id":170,"title":171,"report_number":158,"report_date":159,"published_on":159,"page_count":172,"url":173,"available":61},"7.6 Paulianeus handelen","Nee",[],[207,215],{"kind":124,"topic":208,"change":209,"from":183,"to":183,"source":210},"annual_accounts_filing","ongoing",{"id":211,"category":137,"method":167,"source_type":168,"document":212,"page":56,"section":213,"excerpt":214,"certainty":177,"curator_verified_at":14,"processed_at":178},488384,{"id":170,"title":171,"report_number":158,"report_date":159,"published_on":159,"page_count":172,"url":173,"available":61},"7.2 Depot jaarrekeningen","In onderzoek.",{"kind":124,"topic":216,"change":209,"from":183,"to":183,"source":217},"legality_review",{"id":218,"category":137,"method":167,"source_type":168,"document":219,"page":174,"section":188,"excerpt":189,"certainty":177,"curator_verified_at":14,"processed_at":178},488388,{"id":170,"title":171,"report_number":158,"report_date":159,"published_on":159,"page_count":172,"url":173,"available":61},[],{"values":222,"reports":264},[223,235,247,254,261],{"field":100,"kind":224,"value":101,"state":102,"qualifier":14,"as_of":71,"category":137,"report_number":95,"report_date":71,"source":225,"previous":234,"delta":58,"curator":14,"processing":61,"correction_pending":44,"conflict":14},"amount",{"id":139,"category":137,"method":167,"source_type":168,"document":226,"page":57,"section":230,"excerpt":231,"certainty":232,"curator_verified_at":14,"processed_at":233},{"id":227,"title":228,"report_number":95,"report_date":71,"published_on":71,"page_count":56,"url":229,"available":61},"01M4A8Z1BKEDP6YFPCPB8J8KWT","Financieel verslag  06-10-2026","https:\u002F\u002Ffaillissement.app\u002Fdocuments\u002F01M4A8Z1BKEDP6YFPCPB8J8KWT.pdf","financial_statement_a","Totaal baten                                  € 55.640,80                       € 0,00",0.95,"2026-10-07T04:11:54+00:00",{"value":101,"state":102,"report_number":158,"report_date":159},{"field":107,"kind":224,"value":108,"state":102,"qualifier":14,"as_of":71,"category":137,"report_number":95,"report_date":71,"source":236,"previous":244,"delta":246,"curator":14,"processing":61,"correction_pending":44,"conflict":14},{"id":142,"category":137,"method":167,"source_type":168,"document":237,"page":241,"section":242,"excerpt":243,"certainty":232,"curator_verified_at":14,"processed_at":233},{"id":238,"title":239,"report_number":95,"report_date":71,"published_on":71,"page_count":172,"url":240,"available":61},"01M4A8Z2HVF0ZX709CCF3CXJKV","Verslag:  06-10-2026","https:\u002F\u002Ffaillissement.app\u002Fdocuments\u002F01M4A8Z2HVF0ZX709CCF3CXJKV.pdf",12,"8.6 Bedrag concurrente crediteuren","€ 17.914,29",{"value":245,"state":102,"report_number":158,"report_date":159},17914.29,12496.15,{"field":119,"kind":224,"value":120,"state":102,"qualifier":14,"as_of":71,"category":137,"report_number":95,"report_date":71,"source":248,"previous":253,"delta":58,"curator":14,"processing":61,"correction_pending":44,"conflict":14},{"id":148,"category":137,"method":167,"source_type":168,"document":249,"page":250,"section":251,"excerpt":252,"certainty":232,"curator_verified_at":14,"processed_at":233},{"id":238,"title":239,"report_number":95,"report_date":71,"published_on":71,"page_count":172,"url":240,"available":61},11,"8.2 Pref. vord. van de fiscus","€ 140.868,00",{"value":120,"state":102,"report_number":158,"report_date":159},{"field":113,"kind":255,"value":114,"state":102,"qualifier":14,"as_of":71,"category":137,"report_number":95,"report_date":71,"source":256,"previous":260,"delta":94,"curator":14,"processing":61,"correction_pending":44,"conflict":14},"count",{"id":145,"category":137,"method":167,"source_type":168,"document":257,"page":241,"section":258,"excerpt":259,"certainty":232,"curator_verified_at":14,"processed_at":233},{"id":238,"title":239,"report_number":95,"report_date":71,"published_on":71,"page_count":172,"url":240,"available":61},"8.5 Aantal concurrente crediteuren","3",{"value":158,"state":102,"report_number":158,"report_date":159},{"field":262,"kind":255,"value":14,"state":263,"qualifier":14,"as_of":14,"category":14,"report_number":14,"report_date":14,"source":14,"previous":14,"delta":14,"curator":14,"processing":61,"correction_pending":44,"conflict":14},"employee_count","not_mentioned",{"count":55,"next":14},[266,273,279,286,293,301,308,311,314,317,320,323,330],{"topic":267,"investigation":44,"state":184,"category":137,"source":268},"lease_contracts",{"id":269,"category":137,"method":167,"source_type":168,"document":270,"page":158,"section":271,"excerpt":272,"certainty":190,"curator_verified_at":14,"processed_at":178},488367,{"id":170,"title":171,"report_number":158,"report_date":159,"published_on":159,"page_count":172,"url":173,"available":61},"1.4 Huur","Er is geen sprake van huurovereenkomsten.",{"topic":126,"investigation":61,"state":127,"category":137,"source":274},{"id":275,"category":137,"method":167,"source_type":168,"document":276,"page":95,"section":277,"excerpt":278,"certainty":177,"curator_verified_at":14,"processed_at":178},488369,{"id":170,"title":171,"report_number":158,"report_date":159,"published_on":159,"page_count":172,"url":173,"available":61},"1.5 Oorzaak faillissement","Het Lead Pharma concern hield zich bezig met onderzoek naar en ontw ikkeling van innovatieve therapieën voor de behandeling van auto-immuunziekten en 1 kanker. Voor de financiering van deze activiteiten w as het concern volledig afhankelijk van investeerders en overheidsinstellingen. Medio 2025 w erd het faillissement uitgesproken van dochteronderneming Lead Pharma Medicine B.V. Een doorstart van ",{"topic":280,"investigation":44,"state":184,"category":137,"source":281},"employees",{"id":282,"category":137,"method":167,"source_type":168,"document":283,"page":114,"section":284,"excerpt":285,"certainty":190,"curator_verified_at":14,"processed_at":178},488370,{"id":170,"title":171,"report_number":158,"report_date":159,"published_on":159,"page_count":172,"url":173,"available":61},"2.3 Ontslagaanzegging","Datum Aantal Toelichting 1-12-2025 2 totaal 2",{"topic":287,"investigation":44,"state":184,"category":137,"source":288},"asset_sales",{"id":289,"category":137,"method":167,"source_type":168,"document":290,"page":114,"section":291,"excerpt":292,"certainty":190,"curator_verified_at":14,"processed_at":178},488371,{"id":170,"title":171,"report_number":158,"report_date":159,"published_on":159,"page_count":172,"url":173,"available":61},"3.1 Onroerende zaken","Toelichting onroerende zaken 07-01-2026 Er is geen sprake van onroerende zaken.",{"topic":294,"investigation":44,"state":184,"category":137,"source":295},"receivables_collection",{"id":296,"category":137,"method":167,"source_type":168,"document":297,"page":298,"section":299,"excerpt":300,"certainty":190,"curator_verified_at":14,"processed_at":178},488376,{"id":170,"title":171,"report_number":158,"report_date":159,"published_on":159,"page_count":172,"url":173,"available":61},7,"4.1 Debiteuren","Toelichting debiteuren 07-01-2026 Er is niet gebleken van debiteuren.",{"topic":302,"investigation":44,"state":184,"category":137,"source":303},"security_rights",{"id":304,"category":137,"method":167,"source_type":168,"document":305,"page":55,"section":306,"excerpt":307,"certainty":190,"curator_verified_at":14,"processed_at":178},488377,{"id":170,"title":171,"report_number":158,"report_date":159,"published_on":159,"page_count":172,"url":173,"available":61},"5.3 Beschrijving zekerheden","Er zijn geen zekerheden verstrekt.",{"topic":163,"investigation":44,"state":127,"category":137,"source":309},{"id":166,"category":137,"method":167,"source_type":168,"document":310,"page":174,"section":175,"excerpt":176,"certainty":177,"curator_verified_at":14,"processed_at":178},{"id":170,"title":171,"report_number":158,"report_date":159,"published_on":159,"page_count":172,"url":173,"available":61},{"topic":181,"investigation":61,"state":184,"category":137,"source":312},{"id":186,"category":137,"method":167,"source_type":168,"document":313,"page":174,"section":188,"excerpt":189,"certainty":190,"curator_verified_at":14,"processed_at":178},{"id":170,"title":171,"report_number":158,"report_date":159,"published_on":159,"page_count":172,"url":173,"available":61},{"topic":208,"investigation":61,"state":183,"category":137,"source":315},{"id":211,"category":137,"method":167,"source_type":168,"document":316,"page":56,"section":213,"excerpt":214,"certainty":177,"curator_verified_at":14,"processed_at":178},{"id":170,"title":171,"report_number":158,"report_date":159,"published_on":159,"page_count":172,"url":173,"available":61},{"topic":192,"investigation":61,"state":184,"category":137,"source":318},{"id":194,"category":137,"method":167,"source_type":168,"document":319,"page":56,"section":196,"excerpt":197,"certainty":190,"curator_verified_at":14,"processed_at":178},{"id":170,"title":171,"report_number":158,"report_date":159,"published_on":159,"page_count":172,"url":173,"available":61},{"topic":199,"investigation":61,"state":184,"category":137,"source":321},{"id":201,"category":137,"method":167,"source_type":168,"document":322,"page":56,"section":203,"excerpt":204,"certainty":190,"curator_verified_at":14,"processed_at":178},{"id":170,"title":171,"report_number":158,"report_date":159,"published_on":159,"page_count":172,"url":173,"available":61},{"topic":324,"investigation":61,"state":184,"category":137,"source":325},"proceedings",{"id":326,"category":137,"method":167,"source_type":168,"document":327,"page":241,"section":328,"excerpt":329,"certainty":190,"curator_verified_at":14,"processed_at":178},488387,{"id":170,"title":171,"report_number":158,"report_date":159,"published_on":159,"page_count":172,"url":173,"available":61},"9.1 Naam wederpartijen","Er is geen sprake van procedures.",{"topic":216,"investigation":61,"state":183,"category":137,"source":331},{"id":218,"category":137,"method":167,"source_type":168,"document":332,"page":174,"section":188,"excerpt":189,"certainty":177,"curator_verified_at":14,"processed_at":178},{"id":170,"title":171,"report_number":158,"report_date":159,"published_on":159,"page_count":172,"url":173,"available":61},{"report_id":334,"report_number":95,"published_on":71,"state":335,"since":336,"pages":172,"url":240,"steps":337},"01M4A8Z1CE20E607YJHTKDG5N9","processing","2026-10-08T22:59:45+00:00",[338,342,344,346,349],{"key":339,"state":340,"at":341},"fetched","done","2026-10-07T04:11:53+00:00",{"key":343,"state":340,"at":233},"text",{"key":345,"state":76,"at":14},"extraction",{"key":347,"state":348,"at":14},"review","pending",{"key":350,"state":348,"at":14},"publish",[352,360,379,393,397],{"id":353,"type":354,"group":24,"category":137,"occurred_at":355,"detected_at":72,"date_basis":356,"payload":357,"from_case":14,"source":14},"01M4EGEPCM9G5ERMMW4DC41SA6","topic_changed","2026-10-06T12:00:00+00:00","source",{"from_report":157,"to_report":334,"from_number":158,"to_number":95,"from_date":159,"to_date":71,"topics":358},[359],{"topic":163,"change":182,"from":127,"to":184},{"id":361,"type":362,"group":363,"category":137,"occurred_at":355,"detected_at":72,"date_basis":356,"payload":364,"from_case":14,"source":14},"01M4EGEPCGSBZHY02HZSPPAME0","financial_changed","financial",{"from_report":157,"to_report":334,"from_number":158,"to_number":95,"from_date":159,"to_date":71,"fields":365},[366,373,376],{"field":367,"from":368,"to":370,"delta":372},"estate_claims",{"value":369,"state":102,"qualifier":14},60983.88,{"value":371,"state":102,"qualifier":14},67272.49,6288.61,{"field":107,"from":374,"to":375,"delta":246},{"value":245,"state":102,"qualifier":14},{"value":108,"state":102,"qualifier":14},{"field":113,"from":377,"to":378,"delta":94},{"value":158,"state":102,"qualifier":14},{"value":114,"state":102,"qualifier":14},{"id":380,"type":362,"group":363,"category":137,"occurred_at":355,"detected_at":381,"date_basis":356,"payload":382,"from_case":14,"source":14},"01M4EGENXAE66MCD56W7BKT6VG","2026-10-08T19:39:42+00:00",{"from_report":383,"to_report":384,"from_number":158,"to_number":95,"from_date":159,"to_date":71,"fields":385},"01M4E0VTBHETAV7TM8BWAF90V3","01M4A8YZPXCCPKDPY24767839V",[386],{"field":387,"from":388,"to":390,"delta":392},"estate_account_balance",{"value":389,"state":102,"qualifier":14},36547.61,{"value":391,"state":102,"qualifier":14},5983.86,-30563.75,{"id":394,"type":395,"group":20,"category":132,"occurred_at":355,"detected_at":341,"date_basis":356,"payload":396,"from_case":14,"source":14},"01M4A8Z2J0R5KRG3WF13KTW8YP","report_published",{"report_id":334,"report_number":14,"report_date":71,"title":239,"is_final":44},{"id":398,"type":395,"group":20,"category":132,"occurred_at":355,"detected_at":399,"date_basis":356,"payload":400,"from_case":14,"source":14},"01M4A8Z1BQXW8TG688CBJTF2KN","2026-10-07T04:11:52+00:00",{"report_id":384,"report_number":14,"report_date":71,"title":228,"is_final":44},[402,404,405,406],{"kind":403,"id":238,"title":239,"report_number":95,"report_date":71,"date":71,"pages":172,"category":132,"url":240},"report",{"kind":403,"id":227,"title":228,"report_number":95,"report_date":71,"date":71,"pages":56,"category":132,"url":229},{"kind":403,"id":170,"title":171,"report_number":158,"report_date":159,"date":159,"pages":172,"category":132,"url":173},{"kind":403,"id":407,"title":408,"report_number":158,"report_date":159,"date":159,"pages":56,"category":132,"url":409},"01M4E0VVE7DCMGHYSRWZKJSTH4","Financieel verslag  06-07-2026","https:\u002F\u002Ffaillissement.app\u002Fdocuments\u002F01M4E0VVE7DCMGHYSRWZKJSTH4.pdf",{"official":56,"curator":58,"automated":411,"external":58},77,[],[]]